News

Awards, honors and achievements for the month of April.

Even as the national conversation around diversity, equity and inclusion is muted, Weill Cornell Medicine continues its work to make sure everyone has a seat at the table. That was the message relayed on April 23 by Dr. Linnie Golightly, provost and senior associate dean of academic affairs at CUNY School of Medicine. 

The project will be one of the first major efforts of the Medicaid Policy Impact Initiative, a new cross-campus Cornell program aimed at supporting evidence-based policymaking in Medicaid.

Dr. William Schpero has seen firsthand how public policy drives patient outcomes at the population level, cementing a core idea that continues to guide his work as a health economist: that policy can be a powerful force for improving health equity — or, if poorly designed, a barrier to it. 

For the first time, Weill Cornell Medicine researchers have demonstrated that Hodgkin lymphoma cancer cells from patient samples are immune cells stuck in an “identity crisis.” 

Weill Cornell Medicine investigators made an unexpected finding about how the immune system normally suppresses inappropriate chronic inflammation in the intestine, potentially opening new avenues for therapies against inflammatory bowel disease (IBD), food allergy and other autoimmune conditions.

On April 20, Weill Cornell Medicine awarded the Pioneers in Diversity Awards, recognizing commitment to diversity and inclusion through mentorship, service and advocacy.

Weill Cornell Medicine and University of Southern California investigators have developed and tested the web-based platform, Living Memory Home for Dementia Care Pairs (LMH-4-DCP), which can help reduce grief and improve relationships.

Advancing health equity in medicine requires a clear-eyed understanding of history, a rejection of race-based clinical assumptions and a commitment to transform research into practice, said Dr. Joseph L. Wright, senior vice president and chief health equity officer of the American Academy of Pediatrics (AAP), in his keynote address for Weill Cornell Medicine’s eighth annual Diversity Week. 

A new preclinical study from Weill Cornell Medicine found that the protein caspase-5 (CASP5), long thought to be a foot soldier in the body’s defense against bacterial infection, does not actually help clear invaders the way its close cousin caspase-4 (CASP4) does.

Weill Cornell Medicine investigators have revealed the detailed workings of a cell membrane protein that has essential roles in all animals. 

As executive director for women’s health, a role that complements her position leading obstetrics and gynecology, Dr. Riley will unify, coordinate and drive new paradigms for women’s health care across medical specialties.

Temporarily disabling a protein complex that organizes DNA into loops inside the cell’s nucleus drastically disrupted the three-dimensional structure of the genome, but surprisingly most genes continued to function as usual, Weill Cornell Medicine researchers found. 

A team of Weill Cornell Medicine investigators is working to cross-train the next generation of cancer researchers in cancer biology and the use of artificial intelligence tools for research.

The lecturership recognizes Dr. Lyden's transformative contributions to cancer research.

As states reassess Medicaid coverage following recent federal policy changes and the end of pandemic-era protections, researchers at Weill Cornell Medicine’s Department of Pediatrics, the Cornell Health Policy Center and Ariadne Labs are championing evidence-based health care policy reform and expanded Medicaid coverage for children. 

Soon-to-graduate students of Weill Cornell Medicine-Qatar have gained residency places at prestigious health care institutions in Qatar and the United States, marking another successful Match Day for the college. 

We sat down with Dr. Jia Ruan to learn more about her clinical research and how she thinks it will help lymphoma patients.

A $1 million Research Scholar Grant from the American Cancer Society will help a multi-institution team led by Dr. Bishoy Faltas, associate professor of medicine at Weill Cornell Medicine, to develop new therapy combinations for hard-to-treat urinary tract cancers.

Leaders in the field discussed a shift in research toward looking at shared mechanisms in neurodegenerative diseases at the recent 13th annual Helen and Robert Appel Alzheimer’s Disease Research Institute Symposium held in the Belfer Research Building at Weill Cornell Medicine.